TOCILIZUMAB AS A POTENTIAL NOVEL THERAPY IN PATIENTS DIAGNOSED WITH ADAMANTINOMATOUS CRANIOPHARYNGIOMA

被引：0
|
作者：
Grob, Sydney [1 ,2 ,3 ]
Donson, Andrew [1 ,2 ,3 ]
Prince, Eric [1 ,4 ]
Vijmasi, Trinka [1 ,4 ]
Foreman, Nicholas [1 ,2 ,3 ]
Dahl, Nathan [1 ,2 ,3 ]
Vibhakar, Rajeev [1 ,2 ,3 ]
Mirsky, David [1 ,5 ]
Hankinson, Todd [1 ,4 ]
Levy, Jean Mulcahy [1 ,2 ,3 ]
机构：
[1] Univ Colorado, Aurora, CO USA
[2] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[3] Morgan Adams Fdn Pediat Brain Tumor Res Program, Aurora, CO USA
[4] Childrens Hosp Colorado, Dept Neurosurg, Aurora, CO USA
[5] Childrens Hosp Colorado, Dept Radiol, Aurora, CO USA
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
THER-33
引用
收藏
页码：120 / 121
页数：2
相关论文
共 50 条
  • [41] Tocilizumab as a Novel Therapy for Steroid-Dependent Polymyalgia Rheumatica
    Antiochos, Brendan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (11): : 1047 - 1048
  • [42] Postoperative Metabolic Abnormality in Craniopharyngioma Patients Before Proton Therapy
    Hua, C.
    Conklin, H. M.
    Madey, M. A.
    Indelicato, D. J.
    Shulkin, B. L.
    Merchant, T. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S592 - S592
  • [43] Vascular Abnormalities in Pediatric Craniopharyngioma Patients Treated with Radiation Therapy
    Liu, Arthur K.
    Bagrosky, Brian
    Fenton, Laura Z.
    Gaspar, Laurie E.
    Handler, Michael H.
    McNatt, Sean A.
    Foreman, Nicholas K.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (02) : 227 - 230
  • [44] Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential
    Ghasemi, Kimia
    Ghasemi, Kosar
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (12) : 2360 - 2368
  • [45] TOCILIZUMAB AS POTENTIAL FIRST OPTION BIOLOGIC THERAPY IN SNITZLER'S SYNDROME
    Daia-Iliescu, E. S.
    Buzatu, C.
    Ionescu, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S56 - S57
  • [46] Tocilizumab - A novel therapy for non-organ-specific autoimmune diseases
    Kaly, Lisa
    Rosner, Itzhak
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2012, 26 (01): : 157 - 165
  • [47] TOCILIZUMAB MAYBE A KEY IN THERAPY ON CYTOKINE RELEASE SYNDROME IN ELDERLY PATIENTS WITH SEVERE 2019 NOVEL CORONAVIRUS INFECTION
    Xu, Lengnan
    Mao, Yonghui
    Liu, Xin
    NEPHROLOGY, 2020, 25 : 6 - 7
  • [48] TOCILIZUMAB AS A THERAPEUTIC OPTION FOR RHUPUS PATIENTS REFRACTORY TO CONVENTIONAL THERAPY
    Rossi, D.
    Sciascia, S.
    Manna, E.
    Binello, G. B.
    Modena, V.
    Roccatello, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1004 - 1004
  • [49] Safe and Effective Tocilizumab Therapy in Elderly Patients with Rheumatoid Arthritis
    Specker, Christof
    Kaufmann, Joerg
    Kellner, Herbert
    Kaestner, Peter
    Volberg, Christoph
    Braunewell, Verena
    Aringer, Martin
    Sieburg, Maren
    Meier, Lothar
    Hofmann, Michael
    Flacke, Jan-Paul
    Tony, Hans-Peter
    Fliedner, Gerhard
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] SAFE AND EFFECTIVE TOCILIZUMAB THERAPY IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS
    Specker, C.
    Kaufmann, J.
    Kellner, H.
    Kastner, P.
    Volberg, C.
    Braunewell, V.
    Aringer, A.
    Sieburg, M.
    Meier, L.
    Hofmann, M. W.
    Flacke, J. -P.
    Tony, H. -P.
    Fliedner, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 504 - 504
12345